drugset / Trial / NCT00591188
Capecitabine and Interferon-Alpha in Metastatic Renal Cell Carcinoma Patients With Failure on Interleukin-2 Based Regimens
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The aim of this study is to determine preliminary efficacy of capecitabine and interferon-alpha in second-line after interleukin-2 based regimens in patients with MRCC
Timeline
- Start
- 2006-12
- Primary completion
- 2008-05
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Capecitabine | Small molecule | — | — |
| Subject | interferon alfa-2b | Protein / enzyme biologic | — | — |